Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

MYSTERIOUS: Here s what to expect from johnson johnson s next earnings report - What They Never Told You

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. With a market cap of $366.4 billion, the company operates through its Innovative Medicine and MedTech segments.

The healthcare major is set to unveil its second-quarter results before the markets open on Wednesday, July 16. Ahead of the event, analysts expect JNJ to report a non-GAAP earnings of $2.65 per share, down 6% from the profit of $2.82 per share reported in the year-ago quarter. On a positive note, the company has surpassed the Street’s bottom-line projections in each of the past four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.